Preparation and selection of tumor-hyperreactive immune cells (TURIC)

The present invention relates to a method for preparing a T cell product comprising tumor hyperreactive immune cells (TURIC) and a composition comprising at least one T cell product with TURIC for use in the treatment of cancer patients.